SAN JOSE, Calif., Oct. 4, 2012 (GLOBE NEWSWIRE) -- Intermolecular, Inc. (Nasdaq:IMI)—accelerating research and development (R&D) for semiconductor and clean energy industries—today announced it will release financial results for the fiscal third quarter ended September 30, 2012 after the U.S. financial markets close on Thursday, October 25, 2012. In conjunction with the release, Intermolecular will host a conference call and simultaneous audio-only webcast at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time with David Lazovsky, President and Chief Executive Officer and Peter Eidelman, Chief Financial Officer for Intermolecular.
To participate via telephone, the toll free dial-in number is (877) 251-1860; international callers should dial (224) 357-2386. Please dial-in ten minutes prior to the scheduled conference call time. The call will also be webcast live and archived on Intermolecular's Website at http://ir.intermolecular.com.
About Intermolecular, Inc.
Intermolecular® has pioneered a proprietary approach to accelerate research and development, innovation, and time-to-market for the semiconductor and clean-energy industries. The approach consists of its proprietary HPCTM platform, coupled with its multi-disciplinary team. Through paid collaborative development programs (CDPs) with its customers, Intermolecular develops proprietary technology and intellectual property for its customers focused on advanced materials, processes, integration and device architectures. Founded in 2004, Intermolecular is based in San Jose, California. "Intermolecular" and the Intermolecular logo are registered trademarks; and "HPC" is a trademark of Intermolecular, Inc.; all rights reserved. Learn more at www.intermolecular.com.
The Intermolecular, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=11116
CONTACT: Press Contact: Ed Korczynski, Intermolecular Marketing Communications Director email@example.com +1.408.582.5629 Investor Relations Contact: Gary Hsueh, Intermolecular Sr. Director of Corporate Development and Investor Relations firstname.lastname@example.org +1.408.582.5635